Nurix Therapeutics, Inc. NRIX EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s EV / sales?
- Nurix Therapeutics, Inc. (NRIX) reported EV / sales of 22.7× in Q4 2025.
- How has Nurix Therapeutics, Inc.'s EV / sales changed year-over-year?
- Nurix Therapeutics, Inc.'s EV / sales increased by 14.1% year-over-year, from 19.9× to 22.7×.
- What is the long-term trend for Nurix Therapeutics, Inc.'s EV / sales?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s EV / sales has grown at a -26.2% compound annual growth rate (CAGR), from 86.8× to 19.1×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.